Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

REAL-WORLD EFFECTIVENESS OF RITLECITINIB IN ALOPECIA AREATA PATIENTS IN THE US: A RETROSPECTIVE ANALYSIS USING EHR AND CLAIMS DATA

NCT07821216 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT07821216
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07821216 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
REAL-WORLD EFFECTIVENESS OF RITLECITINIB IN ALOPECIA AREATA PATIENTS IN THE US: A RETROSPECTIVE ANALYSIS USING EHR AND CLAIMS DATA
Lead sponsor
Pfizer
Phase
Observational
Overall status
Active, not recruiting
Start date
August 17, 2026
Completion date
April 20, 2027
Enrollment
7,500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alopecia areata